{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T13:49:56Z","timestamp":1776001796284,"version":"3.50.1"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00347-020-01303-2","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T19:09:53Z","timestamp":1609873793000},"page":"449-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rho-Kinase-Hemmer als neue lokale Therapieoption beim prim\u00e4ren Offenwinkelglaukom","Rho kinase inhibitors as new local therapy option in primary open angle glaucoma"],"prefix":"10.1007","volume":"118","author":[{"given":"C.","family":"Erb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Konieczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"1303_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00417-019-04239-9","volume":"257","author":"S Wey","year":"2019","unstructured":"Wey\u00a0S, Amanullah\u00a0S, Spaeth\u00a0GL et al (2019) Is primary open-angle glaucoma an ocular manifestation of systemic disease? Graefes Arch Clin Exp Ophthalmol 257:665\u2013673","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1303_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/bjo.2005.086769","volume":"90","author":"N Gupta","year":"2006","unstructured":"Gupta\u00a0N, Ang\u00a0LC, No\u00ebl de Tilly\u00a0L et\u00a0al (2006) Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 90:674\u2013678","journal-title":"Br J Ophthalmol"},{"key":"1303_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-0031-1299262","volume":"229","author":"G Michelson","year":"2012","unstructured":"Michelson\u00a0G, W\u00e4rntges\u00a0S, Engelhorn\u00a0T et\u00a0al (2012) Integrit\u00e4t\/Demyelinisierung der Radiatio optica, Morphologie der Papille und Kontrastsensitivit\u00e4t bei Glaukompatienten. Klin Monatsbl Augenheilkd 229:143\u2013148","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1303_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fnins.2018.00363","volume":"12","author":"R Nuzzi","year":"2018","unstructured":"Nuzzi\u00a0R, Dallorto\u00a0L, Rolle\u00a0T (2018) Changes of visual pathway and brain connectivity in glaucoma: a systematic review. Front Neurosci 12:363. https:\/\/doi.org\/10.3389\/fnins.2018.00363","journal-title":"Front Neurosci"},{"issue":"7509","key":"1303_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/bmj.38506.594977.E0","volume":"331","author":"PC Maier","year":"2005","unstructured":"Maier\u00a0PC et al (2005) Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 331(7509):134","journal-title":"BMJ"},{"issue":"4","key":"1303_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s1350-9462(02)00008-3","volume":"21","author":"J Flammer","year":"2002","unstructured":"Flammer\u00a0J, Org\u00fcl\u00a0S, Costa\u00a0VP, Orzalesi\u00a0N, Krieglstein\u00a0GK, Serra\u00a0LM, Renard\u00a0JP, Stef\u00e1nsson\u00a0E (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21(4):359\u2013393. https:\/\/doi.org\/10.1016\/s1350-9462(02)00008-3 (PMID: 12150988)","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"1303_CR7","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","volume":"114","author":"MC eske","year":"2007","unstructured":"Leske\u00a0MC, Heijl\u00a0A, Hyman\u00a0L, Bengtsson\u00a0B, Dong\u00a0L, Yang\u00a0Z, Yang (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114(11):1965\u20131972. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.016 (EMGT Group)","journal-title":"Ophthalmology"},{"issue":"2","key":"1303_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-0032-1328164","volume":"230","author":"C Erb","year":"2013","unstructured":"Erb\u00a0C (2013) Pleiotrope Effekte in der lokalen medikament\u00f6sen Glaukomtherapie. Klin Monbl Augenheilkd 230(2):141\u2013145. https:\/\/doi.org\/10.1055\/s-0032-1328164 (PMID: 23430678)","journal-title":"Klin Monbl Augenheilkd"},{"key":"1303_CR9","series-title":"Cataract and Refractive Surgery Today","first-page":"12","volume-title":"Rho-kinase inhibitor accepted for regulatory review in Europe","author":"CRSTEurope","year":"2018","unstructured":"CRSTEurope (2018) Rho-kinase inhibitor accepted for regulatory review in Europe. Cataract and Refractive Surgery Today, Bd. 11\/12, S 12"},{"issue":"3","key":"1303_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.preteyeres.2007.01.002","volume":"26","author":"M Coca-Prados","year":"2007","unstructured":"Coca-Prados\u00a0M, Escribano\u00a0J (2007) New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a\u00a0multifunctional neuroendocrine gland. Prog Retin Eye Res 26(3):239\u2013262. https:\/\/doi.org\/10.1016\/j.preteyeres.2007.01.002","journal-title":"Prog Retin Eye Res"},{"key":"1303_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.preteyeres.2016.12.004","volume":"57","author":"T Carreon","year":"2017","unstructured":"Carreon\u00a0T, van der Merwe\u00a0E, Fellman\u00a0RL, Johnstone\u00a0M, Bhattacharya\u00a0SK (2017) Aqueous outflow\u2014A continuum from trabecular meshwork to episcleral veins. Prog Retin Eye Res 57:108\u2013133","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"1303_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.survophthal.2019.10.002","volume":"65","author":"C Costagliola","year":"2020","unstructured":"Costagliola\u00a0C, dell\u2019Omo\u00a0R, Agnifili\u00a0L, Bartollino\u00a0S, Fea\u00a0AM, Uva\u00a0MG, Zeppa\u00a0L, Mastropasqua\u00a0L (2020) How many aqueous humor outflow pathways are there? Surv Ophthalmol 65(2):144\u2013170. https:\/\/doi.org\/10.1016\/j.survophthal.2019.10.002 (PMID: 31622628)","journal-title":"Surv Ophthalmol"},{"key":"1303_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fimmu.2018.00145","volume":"9","author":"A J\u00fcnemann","year":"2018","unstructured":"J\u00fcnemann\u00a0A, Hohberger\u00a0B, Rech\u00a0J et al (2018) Agonistic autoantibodies to the \u03b22-Adrenergic receptor involved in the pathogenesis of open-angle glaucoma. Front Immunol 9:145. https:\/\/doi.org\/10.3389\/fimmu.2018.00145","journal-title":"Front Immunol"},{"key":"1303_CR14","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3389\/fimmu.2019.02112","volume":"10","author":"B Hohberger","year":"2019","unstructured":"Hohberger\u00a0B, Kunze\u00a0R, Wallukat\u00a0G et al (2019) Autoantibodies activating the \u03b22-adrenergic receptor characterize patients with primary and secondary glaucoma. Front Immunol 10:2112. https:\/\/doi.org\/10.3389\/fimmu.2019.02112","journal-title":"Front Immunol"},{"key":"1303_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/archopht.1995.01100030037018","volume":"113","author":"L Larsson","year":"1995","unstructured":"Larsson\u00a0L, Rettig\u00a0ES, Brubaker\u00a0RF (1995) Aqueous flow in open-angle glaucoma. Arch Ophthalmol 113:283\u2013286","journal-title":"Arch Ophthalmol"},{"key":"1303_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/exer.1994.1158","volume":"59","author":"RC Tripathi","year":"1994","unstructured":"Tripathi\u00a0RC, Li\u00a0J, Chan\u00a0WF et al (1994) Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 59:723\u2013727","journal-title":"Exp Eye Res"},{"issue":"2","key":"1303_CR17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0043-124084","volume":"235","author":"K Gugleta","year":"2018","unstructured":"Gugleta\u00a0K (2018) Significance of endothelin\u20111 in glaucoma\u2014A\u00a0short overview. Klin Monbl Augenheilkd 235(2):140\u2013145","journal-title":"Klin Monbl Augenheilkd"},{"key":"1303_CR18","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1167\/iovs.04-0649","volume":"46","author":"R Fuchshofer","year":"2005","unstructured":"Fuchshofer\u00a0R, Birke\u00a0M, Welge-L\u00fcssen\u00a0U et al (2005) Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest Ophthalmol Vis Sci 46:568\u2013578","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1167\/iovs.03-0796","volume":"45","author":"J Gottanka","year":"2004","unstructured":"Gottanka\u00a0J, Chan\u00a0D, Eichhorn\u00a0M et al (2004) Effects of TGF-\u03b22 in perfused human eyes. Invest Ophthalmol Vis Sci 45:153\u2013158","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.exer.2010.07.014","volume":"93","author":"R Fuchshofer","year":"2011","unstructured":"Fuchshofer\u00a0R (2011) Pathogenic role of transforming growth factor-\u03b22 in glaucomatous damage to the optic nerve head. Exp Eye Res 93:165\u2013169","journal-title":"Exp Eye Res"},{"key":"1303_CR21","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.1167\/iovs.10-6692","volume":"52","author":"S O\u2019Reilly","year":"2011","unstructured":"O\u2019Reilly\u00a0S, Pollock\u00a0N, Currie\u00a0L et al (2011) Inducers of cross-linked actin networks in trabecular meshwork cells. Invest Ophthalmol Vis Sci 52:7316\u20137324","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2006.12.198","volume":"354","author":"K Yao","year":"2007","unstructured":"Yao\u00a0K, Tan\u00a0J, Gu\u00a0WZ et\u00a0al (2007) Reactive oxygen species mediates the apoptosis induced by transforming growth factor beta(2) in human lens epithelial cells. Biochem Biophys Res Commun 354:278\u2013283","journal-title":"Biochem Biophys Res Commun"},{"key":"1303_CR23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00029330-200702020-00014","volume":"120","author":"Y Zhong","year":"2007","unstructured":"Zhong\u00a0Y, Leung\u00a0CK, Pang\u00a0CP (2007) Glial cells and glaucomatous neuropathy. Chin Med\u00a0J 120:326\u2013335","journal-title":"Chin Med J"},{"key":"1303_CR24","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond\u00a0TR, Marsh\u00a0SE, Stevens\u00a0B (2019) Immune signaling in neurodegeneration. Immunity 50:955\u2013974","journal-title":"Immunity"},{"key":"1303_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pharmthera.2018.10.001","volume":"194","author":"P D\u2019Orl\u00e9ans-Juste","year":"2019","unstructured":"D\u2019Orl\u00e9ans-Juste\u00a0P, Akide Ndunge\u00a0OB, Desbiens\u00a0L, Tanowitz\u00a0HB, Desruisseaux\u00a0MS (2019) Endothelins in inflammatory neurological diseases. Pharmacol Ther 194:145\u2013160","journal-title":"Pharmacol Ther"},{"key":"1303_CR26","doi-asserted-by":"publisher","first-page":"2678017","DOI":"10.1155\/2016\/2678017","volume":"2016","author":"S Li","year":"2016","unstructured":"Li\u00a0S, Zhang\u00a0A, Cao\u00a0W, Sun\u00a0X (2016) Elevated plasma endothelin\u20111 levels in normal tension glaucoma and primary open-angle glaucoma: a meta-analysis. J\u00a0Ophthalmol 2016:2678017","journal-title":"J Ophthalmol"},{"issue":"11","key":"1303_CR27","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1515\/hsz-2013-0181","volume":"394","author":"E Amin","year":"2013","unstructured":"Amin\u00a0E, Dubey\u00a0BN, Zhang\u00a0SC, Gremer\u00a0L, Dvorsky\u00a0R, Moll\u00a0JM, Taha\u00a0MS, Nagel-Steger\u00a0L, Piekorz\u00a0RP, Somlyo\u00a0AV, Ahmadian\u00a0MR (2013) Rho-kinase: regulation, (dys)function, and inhibition. Biol Chem 394(11):1399\u20131410","journal-title":"Biol Chem"},{"issue":"12","key":"1303_CR28","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","volume":"97","author":"Y Rikitake","year":"2005","unstructured":"Rikitake\u00a0Y, Liao\u00a0JK (2005) Rho GTPases, statins, and nitric oxide. Circ Res 97(12):1232\u20131235","journal-title":"Circ Res"},{"issue":"27","key":"1303_CR29","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.2174\/138161209789057986","volume":"15","author":"Q Zhou","year":"2009","unstructured":"Zhou\u00a0Q, Liao\u00a0JK (2009) Rho kinase: an important mediator of atherosclerosis and vascular disease. Curr Pharm Des 15(27):3108\u20133115","journal-title":"Curr Pharm Des"},{"issue":"5","key":"1303_CR30","doi-asserted-by":"publisher","first-page":"E434","DOI":"10.3390\/cells8050434","volume":"8","author":"LLV M\u00f8ller","year":"2019","unstructured":"M\u00f8ller\u00a0LLV, Klip\u00a0A, Sylow\u00a0L (2019) Rho GTPases-emerging regulators of glucose homeostasis and metabolic health. Cells 8(5):E434. https:\/\/doi.org\/10.3390\/cells8050434","journal-title":"Cells"},{"key":"1303_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cmet.2005.06.011","volume":"2","author":"N Furukawa","year":"2005","unstructured":"Furukawa\u00a0N, Ongusaha\u00a0P, Jahng\u00a0WJ, Araki\u00a0K, Choi\u00a0CS, Kim\u00a0HJ, Lee\u00a0YH, Kaibuchi\u00a0K, Kahn\u00a0BB, Masuzaki\u00a0H et al (2005) Role of Rho-kinase in regulation of insulin action and glucose homeostasis. Cell Metab 2:119\u2013129","journal-title":"Cell Metab"},{"issue":"2","key":"1303_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/1381612825666190312115140","volume":"25","author":"F Amin","year":"2019","unstructured":"Amin\u00a0F, Ahmed\u00a0A, Feroz\u00a0A, Khaki\u00a0PSS, Khan\u00a0MS, Tabrez\u00a0S, Zaidi\u00a0SK, Abdulaal\u00a0WH, Shamsi\u00a0A, Khan\u00a0W, Bano\u00a0B (2019) An update on the association of protein kinases with cardiovascular diseases. Curr Pharm Des 25(2):174\u2013183","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1303_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/sgtp.28846","volume":"5","author":"G Loirand","year":"2014","unstructured":"Loirand\u00a0G, Pacaud\u00a0P (2014) Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension. Small GTPases 5(4):1\u201310","journal-title":"Small GTPases"},{"issue":"5","key":"1303_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/jnc.14130","volume":"144","author":"AY Lai","year":"2018","unstructured":"Lai\u00a0AY, McLaurin\u00a0J (2018) Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer\u2019s disease. J\u00a0Neurochem 144(5):659\u2013668","journal-title":"J Neurochem"},{"key":"1303_CR35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/1073858414554954","volume":"21","author":"JL Labandeira-Garcia","year":"2015","unstructured":"Labandeira-Garcia\u00a0JL, Rodr\u00edguez-Perez\u00a0AI, Villar-Cheda\u00a0B, Borrajo\u00a0A, Dominguez-Meijide\u00a0A, Guerra\u00a0MJ (2015) Rho kinase and dopaminergic degeneration: a promising therapeutic target for Parkinson\u2019s disease. Neuroscientist 21:616\u2013629","journal-title":"Neuroscientist"},{"issue":"1","key":"1303_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/APO.0000000000000183","volume":"5","author":"T Nakazawa","year":"2016","unstructured":"Nakazawa\u00a0T (2016) Ocular blood flow and influencing factors for glaucoma. Asia Pac J Ophthalmol (Phila) 5(1):38\u201344","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"1","key":"1303_CR37","first-page":"73","volume":"89","author":"AC Gauthier","year":"2016","unstructured":"Gauthier\u00a0AC, Liu\u00a0J (2016) Neurodegeneration and neuroprotection in glaucoma. Yale J Biol Med 89(1):73\u201379 (eCollection 2016)","journal-title":"Yale J Biol Med"},{"issue":"12","key":"1303_CR38","doi-asserted-by":"publisher","first-page":"e0166915","DOI":"10.1371\/journal.pone.0166915","volume":"11","author":"C Benoist d\u2019Azy","year":"2016","unstructured":"Benoist d\u2019Azy\u00a0C, Pereira\u00a0B, Chiambaretta\u00a0F, Dutheil\u00a0F (2016) Oxidative and anti-oxidative stress markers in chronic glaucoma: a systematic review and meta-analysis. PLoS ONE 11(12):e166915. https:\/\/doi.org\/10.1371\/journal.pone.0166915 (eCollection 2016)","journal-title":"PLoS ONE"},{"key":"1303_CR39","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1167\/iovs.16-20017","volume":"57","author":"AP Khawaja","year":"2016","unstructured":"Khawaja\u00a0AP, Cooke Bailey\u00a0JN, Kang\u00a0JH et al (2016) Assessing the association of mitochondrial genetic variation with primary open-angle glaucoma using gene-set analyses. Invest Ophthalmol Vis Sci 57:5046\u20135052","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JTS.1000167","volume":"3","author":"KK Abu-Amero","year":"2016","unstructured":"Abu-Amero\u00a0KK, Kondkar\u00a0AA, Chalam\u00a0KV (2016) Mitochondrial aberrations and ophthalmic diseases. J\u00a0Transl Sci 3:1\u201311","journal-title":"J Transl Sci"},{"issue":"6","key":"1303_CR41","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1089\/ars.2010.3614","volume":"15","author":"GA Knock","year":"2011","unstructured":"Knock\u00a0GA, Ward\u00a0JP (2011) Redox regulation of protein kinases as a\u00a0modulator of vascular function. Antioxid Redox Signal 15(6):1531\u20131547","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"1303_CR42","doi-asserted-by":"publisher","first-page":"38319","DOI":"10.1038\/srep38319","volume":"7","author":"KY Torrejon","year":"2016","unstructured":"Torrejon\u00a0KY, Papke\u00a0EL, Halman\u00a0JR, Bergkvist\u00a0M, Danias\u00a0J, Sharfstein\u00a0ST, Xie\u00a0Y (2016) TGF\u03b22-induced outflow alterations in a\u00a0bioengineered trabecular meshwork are offset by a\u00a0rho-associated kinase inhibitor. Sci Rep 7(6):38319. https:\/\/doi.org\/10.1038\/srep38319","journal-title":"Sci Rep"},{"key":"1303_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/bs.apha.2016.05.002","volume":"77","author":"M Houde","year":"2016","unstructured":"Houde\u00a0M, Desbiens\u00a0L, D\u2019Orl\u00e9ans-Juste\u00a0P (2016) Endothelin-1: biosynthesis, signaling and vasoreactivity. Adv Pharmacol 77:143\u2013175. https:\/\/doi.org\/10.1016\/bs.apha.2016.05.002","journal-title":"Adv Pharmacol"},{"key":"1303_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1350-9462(99)00015-4","volume":"19","author":"M Wiederholt","year":"2000","unstructured":"Wiederholt\u00a0M, Thieme\u00a0H, Stumpff\u00a0F (2000) The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res 19:271\u2013295","journal-title":"Prog Retin Eye Res"},{"key":"1303_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/bs.pmbts.2015.06.007","volume":"134","author":"ER Tamm","year":"2015","unstructured":"Tamm\u00a0ER, Braunger\u00a0BM, Fuchshofer\u00a0R (2015) Intraocular pressure and the mechanisms involved in resistance of the aqueous humor flow in the trabecular meshwork outflow pathways. Prog Mol Biol Transl Sci 134:301\u2013314","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1303_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00441-011-1274-7","volume":"347","author":"R Fuchshofer","year":"2012","unstructured":"Fuchshofer\u00a0R, Tamm\u00a0ER (2012) The role of TGF\u2011\u03b2 in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res 347:279\u2013290","journal-title":"Cell Tissue Res"},{"issue":"4","key":"1303_CR47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archopht.123.4.458","volume":"123","author":"SC Sacca","year":"2005","unstructured":"Sacca\u00a0SC, Pascotto\u00a0A, Camicione\u00a0P, Capris\u00a0P, Izzotti\u00a0A (2005) Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 123(4):458\u2013463","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"1303_CR48","first-page":"1029","volume":"42","author":"PV Rao","year":"2001","unstructured":"Rao\u00a0PV, Deng\u00a0PF, Kumar\u00a0J, Epstein\u00a0DL (2001) Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y\u201127632. Invest Ophthalmol Vis Sci 42(5):1029\u20131037","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1303_CR49","doi-asserted-by":"publisher","first-page":"C749","DOI":"10.1152\/ajpcell.00317.2009","volume":"298","author":"PP Pattabiraman","year":"2010","unstructured":"Pattabiraman\u00a0PP, Rao\u00a0PV (2010) Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells. Am J Physiol Cell Physiol 298(3):C749\u201363","journal-title":"Am J Physiol Cell Physiol"},{"key":"1303_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0047-6374(89)90017-1","volume":"47","author":"MA Babizhayev","year":"1989","unstructured":"Babizhayev\u00a0MA, Brodskaya\u00a0MW (1989) Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open-angle glaucoma. Mech Ageing Dev 47:145\u2013157","journal-title":"Mech Ageing Dev"},{"key":"1303_CR51","first-page":"563","volume":"21","author":"E Lutjen-Drecoll","year":"1981","unstructured":"Lutjen-Drecoll\u00a0E, Futa\u00a0R, Rohen\u00a0JW (1981) Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 21:563\u2013573","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.exer.2016.08.023","volume":"158","author":"PV Rao","year":"2017","unstructured":"Rao\u00a0PV, Pattabiraman\u00a0PP, Kopczynski\u00a0C (2017) Role of the rho GTPase\/rho kinase signaling pathway in pathogenesis and treatment of glaucoma: bench to bedside research. Exp Eye Res 158:23\u201332","journal-title":"Exp Eye Res"},{"issue":"13","key":"1303_CR53","first-page":"4240","volume":"41","author":"H Thieme","year":"2000","unstructured":"Thieme\u00a0H, Nuskovski\u00a0M, Nass\u00a0JU, Pleyer\u00a0U, Strauss\u00a0O, Wiederholt\u00a0M (2000) Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho\u2011A. Invest Ophthalmol Vis Sci 41(13):4240\u20134246 (PMID: 11095621)","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR54","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jcp.24524","volume":"229","author":"PP Pattabiraman","year":"2014","unstructured":"Pattabiraman\u00a0PP, Maddala\u00a0R, Rao\u00a0PV (2014) Regulation of plasticity and fibrogenic activity of trabecular meshwork cells by Rho GTPase signaling. J\u00a0Cell Physiol 229:927\u2013942","journal-title":"J Cell Physiol"},{"key":"1303_CR55","doi-asserted-by":"publisher","first-page":"7598140","DOI":"10.1155\/2017\/7598140","volume":"2017","author":"T Fujimoto","year":"2017","unstructured":"Fujimoto\u00a0T, Inoue\u00a0T, Ohira\u00a0S, Awai-Kasaoka\u00a0N, Kameda\u00a0T, Inoue-Mochita\u00a0M, Tanihara\u00a0H (2017) Inhibition of rho kinase induces antioxidative molecules and suppresses reactive oxidative species in trabecular meshwork cells. J\u00a0Ophthalmol 2017:7598140. https:\/\/doi.org\/10.1155\/2017\/7598140 (PMID: 28804648; PMCID: PMC5540245)","journal-title":"J Ophthalmol"},{"issue":"5","key":"1303_CR56","first-page":"1029","volume":"42","author":"PV Rao","year":"2001","unstructured":"Rao\u00a0PV, Deng\u00a0PF, Kumar\u00a0J, Epstein\u00a0DL (2001) Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y\u201127632. Invest Ophthalmol Vis Sci 42(5):1029\u20131037","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR57","doi-asserted-by":"publisher","first-page":"19640","DOI":"10.1038\/srep19640","volume":"6","author":"Y Kaneko","year":"2016","unstructured":"Kaneko\u00a0Y, Ohta\u00a0M, Inoue\u00a0T, Mizuno\u00a0K, Isobe\u00a0T, Tanabe\u00a0S, Tanihara\u00a0H (2016) Effects of K\u2011115 (Ripasudil), a\u00a0novel ROCK inhibitor, on trabecular meshwork and Schlemm\u2019s canal endothelial cells. Sci Rep 6:19640","journal-title":"Sci Rep"},{"issue":"3","key":"1303_CR58","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/jop.2014.0146","volume":"31","author":"JW Kiel","year":"2015","unstructured":"Kiel\u00a0JW, Kopczynski\u00a0CC (2015) Effect of AR-13324 on episcleral venous pressure in Dutch belted rabbits. J\u00a0Ocul Pharmacol Ther 31(3):146\u2013151. https:\/\/doi.org\/10.1089\/jop.2014.0146","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"1303_CR59","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1089\/jop.2017.0138","volume":"34","author":"A Kazemi","year":"2018","unstructured":"Kazemi\u00a0A, McLaren\u00a0JW, Kopczynski\u00a0CC, Heah\u00a0TG, Novack\u00a0GD, Sit\u00a0AJ (2018) The effects of Netarsudil ophthalmic solution on aqueous humor dynamics in a\u00a0randomized study in humans. J\u00a0Ocul Pharmacol Ther 34(5):380\u2013386. https:\/\/doi.org\/10.1089\/jop.2017.0138","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"1303_CR60","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.bmcl.2016.03.104","volume":"26","author":"JM Sturdivant","year":"2016","unstructured":"Sturdivant\u00a0JM, Royalty\u00a0SM, Lin\u00a0CW et al (2016) Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma. Bioorg Med Chem Lett 26(10):2475\u20132480. https:\/\/doi.org\/10.1016\/j.bmcl.2016.03.104","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"1303_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/IJG.0b013e3182952213","volume":"24","author":"RF Wang","year":"2015","unstructured":"Wang\u00a0RF, Williamson\u00a0JE, Kopczynski\u00a0C, Serle\u00a0JB (2015) Effect of 0.04\u202f% AR-13324, a\u00a0ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes. J\u00a0Glaucoma 24(1):51\u201354. https:\/\/doi.org\/10.1097\/IJG.0b013e3182952213","journal-title":"J Glaucoma"},{"key":"1303_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2016.04.002","volume":"787","author":"G Li","year":"2016","unstructured":"Li\u00a0G, Mukherjee\u00a0D, Navarro\u00a0I et\u00a0al (2016) Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes. Eur J Pharmacol 787:20\u201331. https:\/\/doi.org\/10.1016\/j.ejphar.2016.04.002","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1303_CR63","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00417-020-04691-y","volume":"258","author":"S Chen","year":"2020","unstructured":"Chen\u00a0S, Waxman\u00a0S, Wang\u00a0C, Atta\u00a0S, Loewen\u00a0R, Loewen\u00a0NA (2020) Dose-dependent effects of netarsudil, a\u00a0rho-kinase inhibitor, on the distal outflow tract. Graefes Arch Clin Exp Ophthalmol 258(6):1211\u20131216. https:\/\/doi.org\/10.1007\/s00417-020-04691-y (PMID: 32372330; PMCID: PMC7237522)","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1303_CR64","first-page":"73","volume":"89","author":"AC Gauthier","year":"2016","unstructured":"Gauthier\u00a0AC, Liu\u00a0J (2016) Neurodegeneration and neuroprotection in glaucoma. Yale J Biol Med 89(1):73\u201379","journal-title":"Yale J Biol Med"},{"issue":"3","key":"1303_CR65","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/cells9030535","volume":"9","author":"S M\u00e9lik Parsadaniantz","year":"2020","unstructured":"M\u00e9lik Parsadaniantz\u00a0S, R\u00e9aux-le Goazigo\u00a0A, Sapienza\u00a0A, Habas\u00a0C, Baudouin\u00a0C (2020) Glaucoma: a degenerative optic neuropathy related to neuroinflammation? Cells 9(3):535. https:\/\/doi.org\/10.3390\/cells9030535","journal-title":"Cells"},{"key":"1303_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.03.008","volume":"189","author":"JC Koch","year":"2018","unstructured":"Koch\u00a0JC, Tatenhorst\u00a0L, Roser\u00a0AE, Saal\u00a0KA, T\u00f6nges\u00a0L, Lingor\u00a0P (2018) ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacol Ther 189:1\u201321. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.03.008","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1303_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainres.2004.05.070","volume":"1018","author":"Y Kitaoka","year":"2004","unstructured":"Kitaoka\u00a0Y, Kitaoka\u00a0Y, Kumai\u00a0T et al (2004) Involvement of RhoA and possible neuroprotective effect of fasudil, a\u00a0Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina. Brain Res 1018(1):111\u2013118","journal-title":"Brain Res"},{"issue":"8","key":"1303_CR68","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/IJG.0b013e318241b83c","volume":"21","author":"B Goldhagen","year":"2012","unstructured":"Goldhagen\u00a0B, Proia\u00a0AD, Epstein\u00a0DL, Rao\u00a0PV (2012) Elevated levels of RhoA in the optic nerve head of human eyes with glaucoma. J\u00a0Glaucoma 21(8):530\u2013538. https:\/\/doi.org\/10.1097\/IJG.0b013e318241b83c","journal-title":"J Glaucoma"},{"issue":"11","key":"1303_CR69","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1167\/iovs.13-13842","volume":"55","author":"K Yamamoto","year":"2014","unstructured":"Yamamoto\u00a0K, Maruyama\u00a0K, Himori\u00a0N et al (2014) The novel Rho kinase (ROCK) inhibitor K\u2011115: a\u00a0new candidate drug for neuroprotective treatment in glaucoma. Invest Ophthalmol Vis Sci 55(11):7126\u20137136. https:\/\/doi.org\/10.1167\/iovs.13-13842","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.exer.2016.07.006","volume":"158","author":"PX Shaw","year":"2017","unstructured":"Shaw\u00a0PX, Sang\u00a0A, Wang\u00a0Y et\u00a0al (2017) Topical administration of a\u00a0Rock\/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury. Exp Eye Res 158:33\u201342. https:\/\/doi.org\/10.1016\/j.exer.2016.07.006","journal-title":"Exp Eye Res"},{"key":"1303_CR71","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fnins.2014.00338","volume":"8","author":"Y Fujita","year":"2014","unstructured":"Fujita\u00a0Y, Yamashita\u00a0T (2014) Axon growth inhibition by RhoA\/ROCK in the central nervous system. Front Neurosci 8:338. https:\/\/doi.org\/10.3389\/fnins.2014.00338","journal-title":"Front Neurosci"},{"key":"1303_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/s0079-6123(02)37028-6","volume":"137","author":"B Ellezam","year":"2002","unstructured":"Ellezam\u00a0B, Dubreuil\u00a0C, Winton\u00a0M et\u00a0al (2002) Inactivation of intracellular Rho to stimulate axon growth and regeneration. Prog Brain Res 137:371\u2013380. https:\/\/doi.org\/10.1016\/s0079-6123(02)37028-6","journal-title":"Prog Brain Res"},{"key":"1303_CR73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.exer.2016.07.006","volume":"158","author":"PX Shaw","year":"2017","unstructured":"Shaw\u00a0PX, Sang\u00a0A, Wang\u00a0Y et\u00a0al (2017) Topical administration of a\u00a0rock\/net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury. Exp Eye Res 158:33\u201342. https:\/\/doi.org\/10.1016\/j.exer.2016.07.006","journal-title":"Exp Eye Res"},{"key":"1303_CR74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2008.01.063","volume":"1201","author":"M Ichikawa","year":"2008","unstructured":"Ichikawa\u00a0M, Yoshida\u00a0J, Saito\u00a0K, Sagawa\u00a0H, Tokita\u00a0Y, Watanabe\u00a0M (2008) Differential effects of two ROCK inhibitors, fasudil and Y\u201127632, on optic nerve regeneration in adult cats. Brain Res 1201:23\u201333. https:\/\/doi.org\/10.1016\/j.brainres.2008.01.063","journal-title":"Brain Res"},{"issue":"3","key":"1303_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/tvst.6.3.22","volume":"6","author":"E Townes-Anderson","year":"2017","unstructured":"Townes-Anderson\u00a0E, Wang\u00a0J, Hal\u00e1sz \u00c9 et al (2017) Fasudil, a\u00a0clinically used ROCK inhibitor, stabilizes Rod photoreceptor synapses after retinal detachment. Transl Vis Sci Technol 6(3):22. https:\/\/doi.org\/10.1167\/tvst.6.3.22","journal-title":"Transl Vis Sci Technol"},{"issue":"Suppl 2","key":"1303_CR76","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.survophthal.2007.08.010","volume":"52","author":"MC Grieshaber","year":"2007","unstructured":"Grieshaber\u00a0MC, Mozaffarieh\u00a0M, Flammer\u00a0J (2007) What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol 52(Suppl 2):S144\u2013S154. https:\/\/doi.org\/10.1016\/j.survophthal.2007.08.010","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"1303_CR77","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/cells8060551","volume":"8","author":"D Strassheim","year":"2019","unstructured":"Strassheim\u00a0D, Gerasimovskaya\u00a0E, Irwin\u00a0D, Dempsey\u00a0EC, Stenmark\u00a0K, Karoor\u00a0V (2019) RhoGTPase in vascular disease. Cells 8(6):551. https:\/\/doi.org\/10.3390\/cells8060551","journal-title":"Cells"},{"issue":"3","key":"1303_CR78","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1167\/iovs.09-4391","volume":"51","author":"TW Hein","year":"2010","unstructured":"Hein\u00a0TW, Rosa\u00a0RH Jr, Yuan\u00a0Z, Roberts\u00a0E, Kuo\u00a0L (2010) Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arterioles. Invest Ophthalmol Vis Sci 51(3):1583\u20131590. https:\/\/doi.org\/10.1167\/iovs.09-4391 (PMID: 19850828; PMCID: PMC2868420)","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1303_CR79","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3109\/02713683.2011.599106","volume":"36","author":"H Tokushige","year":"2011","unstructured":"Tokushige\u00a0H, Waki\u00a0M, Takayama\u00a0Y, Tanihara\u00a0H (2011) Effects of Y\u201139983, a\u00a0selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats. Curr Eye Res 36(10):964\u2013970. https:\/\/doi.org\/10.3109\/02713683.2011.599106","journal-title":"Curr Eye Res"},{"issue":"2","key":"1303_CR80","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00417-018-4191-6","volume":"257","author":"Y Wada","year":"2019","unstructured":"Wada\u00a0Y, Higashide\u00a0T, Nagata\u00a0A, Sugiyama\u00a0K (2019) Effects of ripasudil, a\u00a0rho kinase inhibitor, on blood flow in the optic nerve head of normal rats. Graefes Arch Clin Exp Ophthalmol 257(2):303\u2013311","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"1303_CR81","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10384-017-0524-y","volume":"61","author":"Y Ohta","year":"2017","unstructured":"Ohta\u00a0Y, Takaseki\u00a0S, Yoshitomi\u00a0T (2017) Effects of ripasudil hydrochloride hydrate (K-115), a\u00a0rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits. Jpn J Ophthalmol 61(5):423\u2013432. https:\/\/doi.org\/10.1007\/s10384-017-0524-y","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"1303_CR82","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1167\/iovs.12-9542","volume":"53","author":"LB Potts","year":"2012","unstructured":"Potts\u00a0LB, Ren\u00a0Y, Lu\u00a0G et al (2012) Constriction of retinal arterioles to endothelin-1: requisite role of rho kinase independent of protein kinase C and L\u2011type calcium channels. Invest Ophthalmol Vis Sci 53(6):2904\u20132912. https:\/\/doi.org\/10.1167\/iovs.12-9542","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1303_CR83","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00417-018-3945-5","volume":"256","author":"E Chihara","year":"2018","unstructured":"Chihara\u00a0E, Dimitrova\u00a0G, Chihara\u00a0T (2018) Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a\u00a0comparison with brimonidine. Graefes Arch Clin Exp Ophthalmol 256(7):1257\u20131264. https:\/\/doi.org\/10.1007\/s00417-018-3945-5 (PMID: 29520478; PMCID: PMC6006239)","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1303_CR84","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00054.2020","author":"AA Hopkins","year":"2020","unstructured":"Hopkins\u00a0AA, Murphy\u00a0R, Irnaten\u00a0M, Wallace\u00a0DM, Quill\u00a0B, O\u2019Brien\u00a0C (2020) The role of lamina cribrosa tissue stiffness and fibrosis as fundamental biomechanical drivers of pathological glaucomatous cupping. Am J Physiol Cell Physiol. https:\/\/doi.org\/10.1152\/ajpcell.00054.2020","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"1303_CR85","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/ICU.0000000000000354","volume":"28","author":"JC Downs","year":"2017","unstructured":"Downs\u00a0JC, Girkin\u00a0CA (2017) Lamina cribrosa in glaucoma. Curr Opin Ophthalmol 28(2):113\u2013119. https:\/\/doi.org\/10.1097\/ICU.0000000000000354","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"1303_CR86","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.7.6.6","volume":"7","author":"I Pitha","year":"2018","unstructured":"Pitha\u00a0I, Oglesby\u00a0E, Chow\u00a0A, Kimball\u00a0E, Pease\u00a0ME, Schaub\u00a0J, Quigley\u00a0H (2018) Rho-kinase inhibition reduces myofibroblast differentiation and proliferation of scleral fibroblasts induced by transforming growth factor \u03b2 and experimental glaucoma. Transl Vis Sci Technol 7(6):6. https:\/\/doi.org\/10.1167\/tvst.7.6.6 (PMID: 30479877; PMCID: PMC6238981)","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"1303_CR87","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00417-008-0881-9","volume":"246","author":"C Erb","year":"2008","unstructured":"Erb\u00a0C, Gast\u00a0U, Schremmer\u00a0D (2008) German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol 246(11):1593\u20131601. https:\/\/doi.org\/10.1007\/s00417-008-0881-9 (PMID: 18648841)","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"1303_CR88","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","volume":"106","author":"C Baudouin","year":"1999","unstructured":"Baudouin\u00a0C, Pisella\u00a0PJ, Fillacier\u00a0K, Goldschild\u00a0M, Becquet\u00a0F, De Saint Jean\u00a0M, B\u00e9chetoille\u00a0A (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106(3):556\u2013563. https:\/\/doi.org\/10.1016\/S0161-6420(99)90116-1 (PMID: 10080214)","journal-title":"Ophthalmology"},{"issue":"3","key":"1303_CR89","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","volume":"10","author":"W Lan","year":"2012","unstructured":"Lan\u00a0W, Petznick\u00a0A, Heryati\u00a0S, Rifada\u00a0M, Tong\u00a0L (2012) Nuclear factor-\u03baB: central regulator in ocular surface inflammation and diseases. Ocul Surf 10(3):137\u2013148. https:\/\/doi.org\/10.1016\/j.jtos.2012.04.001 (PMID: 22814642)","journal-title":"Ocul Surf"},{"issue":"4","key":"1303_CR90","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin\u00a0C, Labb\u00e9\u00a0A, Liang\u00a0H, Pauly\u00a0A, Brignole-Baudouin\u00a0F (2010) Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 29(4):312\u2013334. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.03.001 (PMID: 20302969)","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"1303_CR91","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/IJG.0000000000001168","volume":"28","author":"D Tiedemann","year":"2019","unstructured":"Tiedemann\u00a0D, Mouhammad\u00a0ZA, Utheim\u00a0TP, Dartt\u00a0DA, Heegaard\u00a0S, Petrovski\u00a0G, Kolko\u00a0M (2019) Conjunctival goblet cells, the overlooked cells in glaucoma treatment. J\u00a0Glaucoma 28(4):325\u2013333. https:\/\/doi.org\/10.1097\/IJG.0000000000001168 (PMID: 30585937)","journal-title":"J Glaucoma"},{"key":"1303_CR92","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/OPTH.S245915","volume":"14","author":"CB Trelford","year":"2020","unstructured":"Trelford\u00a0CB, Denstedt\u00a0JT, Armstrong\u00a0JJ, Hutnik\u00a0CML (2020) The pro-fibrotic behavior of human tenon\u2019s capsule fibroblasts in medically treated glaucoma patients. Clin Ophthalmol 14:1391\u20131402. https:\/\/doi.org\/10.2147\/OPTH.S245915 (PMID: 32546947; PMCID: PMC7250314)","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"1303_CR93","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1042\/CS20020150","volume":"104","author":"MF Cordeiro","year":"2003","unstructured":"Cordeiro\u00a0MF (2003) Role of transforming growth factor beta in conjunctival scarring. Clin Sci (Lond) 104(2):181\u2013187. https:\/\/doi.org\/10.1042\/CS20020150 (Erratum in: Clin Sci (Lond) 2003; 105(6):723. PMID: 12546640)","journal-title":"Clin Sci (Lond)"},{"key":"1303_CR94","doi-asserted-by":"publisher","first-page":"696328","DOI":"10.1155\/2013\/696328","volume":"2013","author":"S Ka\u0161telan","year":"2013","unstructured":"Ka\u0161telan\u00a0S, Tomi\u0107\u00a0M, Mete\u017e Soldo\u00a0K, Salopek-Rabati\u0107\u00a0J (2013) How ocular surface disease impacts the glaucoma treatment outcome. Biomed Res Int 2013:696328. https:\/\/doi.org\/10.1155\/2013\/696328 (PMID: 24224176; PMCID: PMC3809958)","journal-title":"Biomed Res Int"},{"issue":"Suppl 1","key":"1303_CR95","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12886-015-0134-8","volume":"15","author":"O Yamanaka","year":"2015","unstructured":"Yamanaka\u00a0O, Kitano-Izutani\u00a0A, Tomoyose\u00a0K, Reinach\u00a0PS (2015) Pathobiology of wound healing after glaucoma filtration surgery. BMC Ophthalmol 15(Suppl 1):157. https:\/\/doi.org\/10.1186\/s12886-015-0134-8 (PMID: 26818010; PMCID: PMC4895697)","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"1303_CR96","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/jop.2016.0085","volume":"33","author":"H Yamada","year":"2017","unstructured":"Yamada\u00a0H, Yoneda\u00a0M, Inaguma\u00a0S, Gosho\u00a0M, Murasawa\u00a0Y, Isogai\u00a0Z, Zako\u00a0M (2017) A rho-associated kinase inhibitor protects permeability in a\u00a0cell culture model of ocular disease, and reduces aqueous flare in anterior uveitis. J\u00a0Ocul Pharmacol Ther 33(3):176\u2013185. https:\/\/doi.org\/10.1089\/jop.2016.0085 (PMID: 28157424)","journal-title":"J Ocul Pharmacol Ther"},{"key":"1303_CR97","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.exer.2016.07.001","volume":"149","author":"A Futakuchi","year":"2016","unstructured":"Futakuchi\u00a0A, Inoue\u00a0T, Fujimoto\u00a0T, Inoue-Mochita\u00a0M, Kawai\u00a0M, Tanihara\u00a0H (2016) The effects of ripasudil (K-115), a\u00a0rho kinase inhibitor, on activation of human conjunctival fibroblasts. Exp Eye Res 149:107\u2013115. https:\/\/doi.org\/10.1016\/j.exer.2016.07.001 (PMID: 27394186)","journal-title":"Exp Eye Res"},{"issue":"2","key":"1303_CR98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cbf.3382","volume":"37","author":"DG Ibrahim","year":"2019","unstructured":"Ibrahim\u00a0DG, Ko\u00a0JA, Iwata\u00a0W, Okumichi\u00a0H, Kiuchi\u00a0Y (2019) An in vitro study of scarring formation mediated by human tenon fibroblasts: effect of Y\u201127632, a\u00a0rho kinase inhibitor. Cell Biochem Funct 37(2):113\u2013124. https:\/\/doi.org\/10.1002\/cbf.3382 (PMID: 30773659; PMCID: PMC6646872)","journal-title":"Cell Biochem Funct"},{"key":"1303_CR99","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/bs.pbr.2015.04.014","volume":"220","author":"S Van de Velde","year":"2015","unstructured":"Van de Velde\u00a0S, Van Bergen\u00a0T, Vandewalle\u00a0E, Kindt\u00a0N, Castermans\u00a0K, Moons\u00a0L, Stalmans\u00a0I (2015) Rho kinase inhibitor AMA0526 improves surgical outcome in a\u00a0rabbit model of glaucoma filtration surgery. Prog Brain Res 220:283\u2013297. https:\/\/doi.org\/10.1016\/bs.pbr.2015.04.014 (PMID: 26497796)","journal-title":"Prog Brain Res"},{"issue":"11","key":"1303_CR100","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","volume":"125","author":"AP Tanna","year":"2018","unstructured":"Tanna\u00a0AP, Johnson\u00a0M (2018) Rho kinase inhibitors as a\u00a0novel treatment for glaucoma and ocular hypertension. Ophthalmology 125(11):1741\u20131756. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.040 (PMID: 30007591; PMCID: PMC6188806)","journal-title":"Ophthalmology"},{"issue":"6","key":"1303_CR101","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2147\/OPTH.S216907","volume":"14","author":"S Kusuhara","year":"2020","unstructured":"Kusuhara\u00a0S, Nakamura\u00a0M (2020) Ripasudil hydrochloride hydrate in the treatment of glaucoma: safety, efficacy, and patient selection. Clin Ophthalmol 14(6):1229\u20131236. https:\/\/doi.org\/10.2147\/OPTH.S216907 (PMID: 32440089; PMCID: PMC7212985)","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1303_CR102","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10384-018-0599-0","volume":"62","author":"K Inoue","year":"2018","unstructured":"Inoue\u00a0K, Ishida\u00a0K, Tomita\u00a0G (2018) Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin\/timolol fixed combination therapy or adding ripasudil. Jpn J Ophthalmol 62(4):508\u2013516. https:\/\/doi.org\/10.1007\/s10384-018-0599-0 (PMID: 29797109)","journal-title":"Jpn J Ophthalmol"},{"key":"1303_CR103","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2147\/OPTH.S154001","volume":"12","author":"L Dasso","year":"2018","unstructured":"Dasso\u00a0L, Al-Khaled\u00a0T, Sonty\u00a0S, Aref\u00a0AA (2018) Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date. Clin Ophthalmol 12:1939\u20131944. https:\/\/doi.org\/10.2147\/OPTH.S154001 (PMID: 30323550; PMCID: PMC6177382)","journal-title":"Clin Ophthalmol"},{"key":"1303_CR104","unstructured":"Produktinformation zu Rhopressa. https:\/\/rhopressa.com\/hcp\/assets\/pdf\/RHOPRESSA-Prescribing-Information.pdf. Zugegriffen: 27. Sept. 2020"},{"issue":"1","key":"1303_CR105","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41433-019-0671-0","volume":"34","author":"NA Mehran","year":"2020","unstructured":"Mehran\u00a0NA, Sinha\u00a0S, Razeghinejad\u00a0R (2020) New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost. Eye (Lond) 34(1):72\u201388. https:\/\/doi.org\/10.1038\/s41433-019-0671-0 (PMID: 31695162; PMCID: PMC7002400)","journal-title":"Eye (Lond)"},{"issue":"10","key":"1303_CR106","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.bmcl.2016.03.104","volume":"26","author":"JM Sturdivant","year":"2016","unstructured":"Sturdivant\u00a0JM, Royalty\u00a0SM, Lin\u00a0CW, Moore\u00a0LA, Yingling\u00a0JD, Laethem\u00a0CL, Sherman\u00a0B, Heintzelman\u00a0GR, Kopczynski\u00a0CC, deLong\u00a0MA (2016) Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma. Bioorg Med Chem Lett 26(10):2475\u20132480. https:\/\/doi.org\/10.1016\/j.bmcl.2016.03.104 (PMID: 27072905)","journal-title":"Bioorg Med Chem Lett"},{"key":"1303_CR107","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2019.01.003","volume":"200","author":"MY Kahook","year":"2019","unstructured":"Kahook\u00a0MY, Serle\u00a0JB, Mah\u00a0FS, Kim\u00a0T, Raizman\u00a0MB, Heah\u00a0T, Ramirez-Davis\u00a0N, Kopczynski\u00a0CC, Usner\u00a0DW, Novack\u00a0GD, ROCKET\u20112 Study Group (2019) Long-term safety and ocular hypotensive efficacy evaluation of netarsudil ophthalmic solution: rho kinase elevated IOP treatment trial (ROCKET-2). Am J Ophthalmol 200:130\u2013137. https:\/\/doi.org\/10.1016\/j.ajo.2019.01.003 (PMID: 30653957)","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1303_CR108","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","volume":"15","author":"DA Hollander","year":"2004","unstructured":"Hollander\u00a0DA, Aldave\u00a0AJ (2004) Drug-induced corneal complications. Curr Opin Ophthalmol 15(6):541\u2013548. https:\/\/doi.org\/10.1097\/01.icu.0000143688.45232.15 (PMID: 15523201)","journal-title":"Curr Opin Ophthalmol"},{"key":"1303_CR109","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00347-015-0005-y","volume":"112","author":"C Erb","year":"2015","unstructured":"Erb\u00a0C (2015) Funktionelle St\u00f6rungen im zeitlichen Verlauf der Glaukomerkrankung. Ophthalmologe 112:402\u2013409","journal-title":"Ophthalmologe"},{"key":"1303_CR110","unstructured":"Produktinformation zu Rocklatan. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/208259s000lbl.pdf. Zugegriffen: 20. Okt. 2020"},{"issue":"4","key":"1303_CR111","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1007\/s12325-020-01277-2","volume":"37","author":"S Asrani","year":"2020","unstructured":"Asrani\u00a0S, Bacharach\u00a0J, Holland\u00a0E, McKee\u00a0H, Sheng\u00a0H, Lewis\u00a0RA, Kopczynski\u00a0CC, Heah\u00a0T (2020) Fixed-dose combination of netarsudil and latanoprost in ocular hypertension and open-angle glaucoma: pooled efficacy\/safety analysis of phase 3 MERCURY\u20111 and -2. Adv Ther 37(4):1620\u20131631. https:\/\/doi.org\/10.1007\/s12325-020-01277-2 (PMID: 32166538; PMCID: PMC7140751)","journal-title":"Adv Ther"},{"key":"1303_CR112","doi-asserted-by":"publisher","first-page":"104469","DOI":"10.1016\/j.phrs.2019.104469","volume":"149","author":"SK Shahbaz","year":"2019","unstructured":"Shahbaz\u00a0SK, Sadeghi\u00a0M, Koushki\u00a0K et al (2019) Regulatory T cells: possible mediators for the anti-inflammatory action of statins. Pharmacol Res 149:104469. https:\/\/doi.org\/10.1016\/j.phrs.2019.104469","journal-title":"Pharmacol Res"},{"issue":"7","key":"1303_CR113","doi-asserted-by":"publisher","first-page":"e002113","DOI":"10.1161\/JAHA.115.002113","volume":"4","author":"A Cai","year":"2015","unstructured":"Cai\u00a0A, Zhou\u00a0Y, Li\u00a0L (2015) Rho-GTPase and atherosclerosis: pleiotropic effects of statins. J\u00a0Am Heart Assoc 4(7):e2113. https:\/\/doi.org\/10.1161\/JAHA.115.002113 (PMID: 26124206; PMCID: PMC4608090)","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"1303_CR114","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1167\/iovs.04-0776","volume":"46","author":"J Song","year":"2005","unstructured":"Song\u00a0J, Deng\u00a0PF, Stinnett\u00a0SS, Epstein\u00a0DL, Rao\u00a0PV (2005) Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci 46(7):2424\u20132432. https:\/\/doi.org\/10.1167\/iovs.04-0776 (PMID: 15980231)","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR115","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1167\/iovs.13-12712","volume":"55","author":"G Villarreal Jr.","year":"2014","unstructured":"Villarreal\u00a0G Jr., Chatterjee\u00a0A, Oh\u00a0SS et\u00a0al (2014) Pharmacological regulation of SPARC by lovastatin in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 55:1657\u20131665","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1303_CR116","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/archopht.124.5.665","volume":"124","author":"T Nagaoka","year":"2006","unstructured":"Nagaoka\u00a0T, Takahashi\u00a0A, Sato\u00a0E et\u00a0al (2006) Effect of systemic administration of imvastatin on retinal circulation. Arch Ophthalmol 124:665\u2013670","journal-title":"Arch Ophthalmol"},{"key":"1303_CR117","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.ophtha.2010.03.003","volume":"117","author":"HC Lin","year":"2010","unstructured":"Lin\u00a0HC et al (2010) Comparison of comorbid conditions between open-angle glaucoma patients and a\u00a0control cohort: a\u00a0casecontrol study. Ophthalmology 117:2088\u20132095","journal-title":"Ophthalmology"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-020-01303-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T16:02:45Z","timestamp":1674835365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-020-01303-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":117,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1303"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01303-2","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"11 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Erb erh\u00e4lt Vortragshonorare sowie Reisekostenerstattungen von den Firmen Allergan, Aerie, Bausch & Lomb, Bayer, Glaucos, Novartis, OmniVision, Thea, Santen, Haag-Streit, VISUfarma, Zeiss. K.\u00a0Konieczka gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}